|
1
|
Shaw JE, Sicree RA and Zimmet PZ: Global
estimates of the prevalence of diabetes for 2010 and 2030. Diabetes
Res Clin Pract. 87:4–14. 2010. View Article : Google Scholar
|
|
2
|
Olokoba AB, Obateru OA and Olokoba LB:
Type 2 diabetes mellitus: a review of current trends. Oman Med J.
27:269–273. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liang H, Balas B, Tantiwong P, Dube J,
Goodpaster BH, O'Doherty RM, DeFronzo RA, Richardson A, Musi N and
Ward WF: Whole body overexpression of PGC-1α has opposite effects
on hepatic and muscle insulin sensitivity. Am J Physiol Endocrinol
Metab. 296:E945–E954. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kraegen EW, Clark PW, Jenkins AB, Daley
EA, Chisholm DJ and Storlien LH: Development of muscle insulin
resistance after liver insulin resistance in high-fat-fed rats.
Diabetes. 40:1397–1403. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bajaj M and Defronzo RA: Metabolic and
molecular basis of insulin resistance. J Nucl Cardiol. 10:311–323.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yamada N: Molecular basis of metabolic
syndrome: insulin resistance. Nihon Rinsho. 64(Suppl 9): 23–29.
2006.In Japanese.
|
|
7
|
Russell AP: PGC-1alpha and exercise:
important partners in combating insulin resistance. Curr Diabetes
Rev. 1:175–181. 2005. View Article : Google Scholar
|
|
8
|
Handschin C and Spiegelman BM: Peroxisome
proliferator activated receptor gamma coactivator 1 coactivators,
energy homeostasis, and metabolism. Endocr Rev. 27:728–735. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu W, Guo T, Zhang Y, Jiang X, Zhang Y,
Zen K, Yu B and Zhang CY: The inhibitory effect of dexamethasone on
platelet derived growth factor-induced vascular smooth muscle cell
migration through up-regulating PGC-1α expression. Exp Cell Res.
317:1083–1092. 2011. View Article : Google Scholar
|
|
10
|
Zhang Y, Liu C, Zhu L, Jiang X, Chen X, Qi
X, Liang X, Jin S, Zhang P, Li Q, et al: PGC-1alpha inhibits oleic
acid induced proliferation and migration of rat vascular smooth
muscle cells. PLoS One. 2:e11372007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang X, Zhang Y, Hou D, Zhu L, Xu W, Ding
L, Qi X, Sun G, Liu C, Zhang J, et al: 17beta-estradiol inhibits
oleic acid-induced rat VSMC proliferation and migration by
restoring PGC-1alpha expression. Mol Cell Endocrinol. 315:74–80.
2010. View Article : Google Scholar
|
|
12
|
Zhu L, Sun G, Zhang H, Zhang Y, Chen X,
Jiang X, Jiang X, Krauss S, Zhang J, Xiang Y and Zhang CY:
PGC-1alpha is a key regulator of glucose-induced proliferation and
migration in vascular smooth muscle cells. PLoS One. 4:e41822009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Koo SH, Satoh H, Herzig S, Lee CH, Hedrick
S, Kulkarni R, Evans RM, Olefsky J and Montminy M: PGC-1 promotes
insulin resistance in liver through PPAR-alpha-dependent induction
of TRB-3. Nat Med. 10:530–534. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Puigserver P, Rhee J, Donovan J, Walkey
CJ, Yoon JC, Oriente F, Kitamura Y, Altomonte J, Dong H, Accili D
and Spiegelman BM: Insulin-regulated hepatic gluconeogenesis
through FOXO1-PGC-1α interaction. Nature. 423:550–555. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rhee J, Inoue Y, Yoon JC, Puigserver P,
Fan M, Gonzalez FJ and Spiegelman BM: Regulation of hepatic fasting
response by PPARgamma coactivator-1α (PGC-1): requirement for
hepatocyte nuclear factor 4a in gluconeogenesis. Proc Natl Acad Sci
USA. 100:4012–4017. 2003. View Article : Google Scholar
|
|
16
|
Griffiths-Jones S, Grocock RJ, van Dongen
S, Bateman A and Enright AJ: miRBase: microRNA sequences, targets
and gene nomenclature. Nucleic Acids Res. 34:D140–D144. 2006.
View Article : Google Scholar :
|
|
17
|
Wang C, Yang C, Chen X, Yao B, Yang C, Zhu
C, Li L, Wang J, Li X, Shao Y, et al: Altered profile of seminal
plasma microRNAs in the molecular diagnosis of male infertility.
Clin Chem. 57:1722–1731. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu R, Zhang C, Hu Z, Li G, Wang C, Yang
C, Huang D, Chen X, Zhang H, Zhuang R, et al: A five-microRNA
signature identified from genome-wide serum microRNA expression
profiling serves as a fingerprint for gastric cancer diagnosis. Eur
J Cancer. 47:784–791. 2011. View Article : Google Scholar
|
|
19
|
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K,
Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs
in serum: a novel class of biomarkers for diagnosis of cancer and
other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen X, Hu Z, Wang W, Ba Y, Ma L, Zhang C,
Wang C, Ren Z, Zhao Y, Wu S, et al: Identification of ten serum
microRNAs from a genome-wide serum microRNA expression pro?le as
novel noninvasive biomarkers for nonsmall cell lung cancer
diagnosis. Int J Cancer. 130:1620–1628. 2012. View Article : Google Scholar
|
|
21
|
Fernandez-Valverde SL, Taft RJ and Mattick
JS: MicroRNAs in β-cell biology, insulin resistance, diabetes and
its complications. Diabetes. 60:1825–1831. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Trajkovski M, Hausser J, Soutschek J, Bhat
B, Akin A, Zavolan M, Heim MH and Stoffel M: MicroRNAs 103 and 107
regulate insulin sensitivity. Nature. 474:649–653. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ling HY, Ou HS, Feng SD, Zhang XY, Tuo QH,
Chen LX, Zhu BY, Gao ZP, Tang CK, Yin WD, et al: CHANGES IN
microRNA (miR) profile and effects of miR-320 in insulin-resistant
3T3-L1 adipocytes. Clin Exp Pharmacol Physiol. 36:e32–e39. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gallagher IJ, Scheele C, Keller P, Nielsen
AR, Remenyi J, Fischer CP, Roder K, Babraj J, Wahlestedt C,
Hutvagner G, et al: Integration of microRNA changes in vivo
identifies novel molecular features of muscle insulin resistance in
type 2 diabetes. Genome Med. 2:92010. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Aoi W, Naito Y, Mizushima K, Takanami Y,
Kawai Y, Ichikawa H and Yoshikawa T: The microRNA miR 696 regulates
PGC-1{α} in mouse skeletal muscle in response to physical activity.
Am J Physiol Endocrinol Metab. 298:E799–E806. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Klaunig JE, Goldblatt PJ, Hinton DE,
Lipsky MM and Trump BF: Mouse liver cell culture. II. Primary
culture. In Vitro. 17:926–934. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yoon JC, Puigserver P, Chen G, Donovan J,
Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, et al:
Control of hepatic gluconeogenesis through the transcriptional
coactivator PGC-1. Nature. 413:131–138. 2001. View Article : Google Scholar
|
|
28
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sayed D and Abdellatif M: MicroRNAs in
development and disease. Physiol Rev. 91:827–887. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Poy MN, Eliasson L, Krutzfeldt J, Kuwajima
S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P
and Stoffel M: A pancreatic islet-specific microRNA regulates
insulin secretion. Nature. 432:226–230. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Frost RJ and Olson EN: Control of glucose
homeostasis and insulin sensitivity by the Let-7 family of
microRNAs. Proc Natl Acad Sci USA. 108:21075–21080. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
He A, Zhu L, Gupta N, Chang Y and Fang F:
Overexpression of micro ribonucleic acid 29, highly up-regulated in
diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes.
Mol Endocrinol. 21:2785–2794. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pandey AK, Verma G, Vig S, Srivastava S,
Srivastava AK and Datta M: miR-29a levels are elevated in the db/db
mice liver and its overexpression leads to attenuation of insulin
action on PEPCK gene expression in HepG2 cells. Mol Cell
Endocrinol. 332:125–133. 2011. View Article : Google Scholar
|
|
35
|
Peschiaroli A, Giacobbe A, Formosa A,
Markert EK, Bongiorno-Borbone L, Levine AJ, Candi E, D'Alessandro
A, Zolla L, Finazzi Agrò A and Melino G: miR-143 regulates
hexokinase 2 expression in cancer cells. Oncogene. 32:797–802.
2013. View Article : Google Scholar
|
|
36
|
Kefas B, Comeau L, Erdle N, Montgomery E,
Amos S and Purow B: Pyruvate kinase M2 is a target of the
tumor-suppressive microRNA-326 and regulates the survival of glioma
cells. Neurooncol. 12:1102–1112. 2010.
|
|
37
|
Vinciguerra M, Sgroi A, Veyrat-Durebex C,
Rubbia-Brandt L, Buhler LH and Foti M: Unsaturated fatty acids
inhibit the expression of tumor suppressor phosphatase and tensin
homolog (PTEN) via microRNA-21 up-regulation in hepatocytes.
Hepatology. 49:1176–1184. 2009. View Article : Google Scholar
|
